EDINBURGH, Scotland, Sept. 4, 2019 /PRNewswire/ — CALCIVIS, a medical devices company focused on revolutionising the management of tooth decay and enabling preventive dentistry, announces it has closed the final part of a £4.5 million equity funding round led by Edinburghbased business angel investment syndicate, Archangels, and supported by the Scottish Investment Bank. The proceeds will be used to support the Company’s development as it anticipates Pre-Market Approval...
Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has received its first purchase order for 20,000 units of its VISITECT® CD4 Advanced Disease test (order value c. £80k) from its partner company in Zimbabwe. Whilst the VISITECT® CD4 Advanced Disease test is currently undergoing review by the UNITAID-funded Expert Review Panel for Diagnostics (“ERPD”), the...
Cutitronics, a University of Strathclyde spin-out that’s raised two funding rounds from FTSE100 chemicals giant Croda International, has doubled the size of its team as it prepares to release its maiden product next year. The company has hired seven members of staff since the beginning of 2019 to take its total headcount up to 14. Further appointments are expected to be made through the remainder...
A new way of concentrating radiotherapy dose in tumours, while minimising damage to healthy cells, has been proposed in research led by scientists at the University of Strathclyde. The study proposes that focusing high-energy particle beams on a small spot deep inside the body could potentially enable clinicians to target cancerous tumours precisely, while reducing the dose to surrounding tissue. External beam radiotherapy involves treating patients with...
Scottish Enterprise to support R&D growth of University of the West of Scotland spin-out company Novosound, the fast growing SME and developer of a ground-breaking technique to mass-manufacture printable ultrasound sensors, has received a £1M grant from Scottish Enterprise as part of a £2M project which will rapidly scale up the company’s R&D activity and recruit new, highly skilled staff. The company, which is based...
A new way of detecting liver disease decades before it can become fatal has been developed by a team of scientists at the University of Dundee and NHS Tayside. It comes as clinicians warn of a `ticking time bomb’ of alcohol-related and obesity-related liver diseases. Liver disease, which is notoriously asymptomatic, has become the second most common cause of death in under 65 year-olds in...